3,4-methylenedioxyamphetamine has been researched along with Emphysema, Mediastinal in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, AJ | 1 |
| Drew, S | 1 |
| Rees, GM | 1 |
| Rezvani, K | 1 |
| Kurbaan, AS | 1 |
| Brenton, D | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Emphysema, Mediastinal
| Article | Year |
|---|---|
'Ecstasy' induced pneumomediastinum.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Designer Drugs; Humans; Male; Mediastinal Emphysema; N-Me | 1993 |
Ecstasy induced pneumomediastinum.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Humans; Male; Mediastinal Emphysema; Substance-Rel | 1996 |